Envision Pharma Group

Are you struggling to extract meaningful insights from the vast ocean of medical affairs data?   In our latest blog series, we dive deep into the 4Sight approach – the powerful combination of platform, people, and process to transform raw data into outstanding medical affairs performance.    The first installment explores the crucial role of a dedicated medical AI platform in overcoming challenges, generating actionable insights, and achieving medical value.   Discover how our own dedicated AI platform, OKRA.ai, has been used to help our clients track insights, uncover trends, and fuel strategic decisions. 👉 https://lnkd.in/d8bT_Fpp   #MedicalAffairs #HealthcareInnovation #AIHealthCare

How is the evolving drug pipeline reshaping commercialization strategies? We are re-sharing insights from our Chief Commercial Officer, Dominic Marasco, RPh, and the critical role medical affairs in this transformation. Discover how integrating medical insights into commercialization processes is driving better outcomes for patients, providers, and payers. https://lnkd.in/e9-uadyX #Pharma #Commercialization #MedicalAffairs #HealthcareInnovation #PatientOutcomes

Last week, Loubna Bouarfa had the privilege of participating in The Brookings Institution event: "The state of US AI innovation and readiness: A conversation with OSTP Director Arati Prabhakar."   Here are her key takeaways from the discussion, highlighting the transformative potential of AI in healthcare and the importance of strategic collaboration to drive innovation.   AI's potential in drug development: AI models can drastically reduce the time needed to design and approve new drugs – from decades to months. This leap forward can be achieved not through large language models but by using large knowledge models specifically designed for this purpose. The challenge of clinical data access: For AI to revolutionize drug development, it needs to be trained on extensive clinical data. However, access and ownership of this data are complex issues. Addressing this barrier is crucial for AI to continue advancing healthcare innovation. Collaboration with regulatory bodies: Public initiatives and collaboration between government and private sector are crucial. These partnerships aim to use AI models to accelerate the drug approval process, ensuring that new treatments can reach patients faster while maintaining safety and efficacy standards. At Envision, we implement an AI platform with best-in-class technology. Our AI models are large knowledge models trained on thousands of medical ontologies, ensuring that the insights generated are more precise, relevant, and reliable. Watch the event here: https://lnkd.in/ea24QkX2 #AI #Healthcare #Innovation #DrugDevelopment #BrookingsEvent #PublicHealth #TechInnovation 

We’re excited to share insights from the ISMPP (International Society for Medical Publication Professionals) webinar "The AI evolution: Medical communications in the digital age," in celebration of #MedComms Day! Dr. Yahya Anvar, General Manager of @OKRA.ai, imparts his insights on the transformative impact of generative AI on scientific communication within the life sciences industry. 🔹 Revolutionizing healthcare: AI manages information flow and aids decision-making 🔹 Addressing information overload: Automates processes, easing the burden on healthcare professionals 🔹 Bias and fairness: Mitigating biases in AI models is crucial for fair representation  🔹 Ethics and trust: Ethical considerations and transparency are vital for AI adoption  🔹 Explainable AI: Transparency and accountability are key to understanding AI decisions and building trust Dr. Anvar's insights highlight the importance of a holistic approach to integrating AI into healthcare, emphasizing responsible AI implementation, ethical guidelines, and continuous improvement through integrated solutions.  🔗 Learn more here: https://lnkd.in/eUZpeePu #AI #HealthcareInnovation #EthicalAI #ISMPP #MedicalCommunications #DigitalHealth #GenerativeAI #AIinHealthcare #ResponsibleAI #WebinarTakeaways #MedCommsDay 

4Sight is a comprehensive solution that aligns the right combination of platform, people, and process to empower teams and drive outstanding performance in medical affairs. At the core of 4Sight is the recognition that even the most advanced tools and platforms are only as effective as the people and processes that support them. Discover 4Sight and unlock strategies to elevate your medical affairs performance. Download eBook now 👇 https://lnkd.in/duRcumNv #4Sight #Envision #eBook #AI

4Sight by Envision is a breakthrough in creating a high-performance medical insights journey. 4Sight represents an innovative approach that emphasizes the importance of people and processes alongside advanced tools and platforms. At Envision, we recognize that even the most cutting-edge AI technology is only as effective as the people and process structure behind it. Paul Archer, Head of Corporate Business Development & Growth Strategy at Envision, recently shared his insights on 4Sight. Discover from Paul why the 4Sight approach is essential for achieving peak performance in the medical affairs insights journey. 🎥 Watch the video to learn more 👇 #MedicalAffairs #Innovation #4SightByEnvision #EPG 

Envision Pharma Group is proud to announce the appointment of William Shirey as President of Life Science Commercialization. With over 25 years of experience in sales, distribution, and commercialization strategy within the biopharmaceutical and orphan drug marketplace, Bill is set to drive our corporate growth and strengthen our client relationships. https://lnkd.in/gd33NJKz #EnvisionPharma #Envisionaries #LifeSciences #Commercialization #HealthcareInnovation #Biopharma #PharmaceuticalIndustry #Leadership #CorporateGrowth

Envision Pharma Group is thrilled to sponsor the Alliance for Regenerative Medicine's #CellandGene Meeting on the Mesa! As part of this event, we are excited to host a panel discussion titled "Anatomy of a CGT Launch: Operationalizing Cell and Gene Therapy." This session will explore the unique challenges and strategies of launching cell and gene therapies (CGT). Our panel will cover key areas including market access and reimbursement, logistical coordination, regulatory navigation, strategic planning and execution, and cross-functional team coordination. Don't miss out on this opportunity to dive deep into the multifaceted aspects of CGT launches and network with leading experts in the field. Join us and be part of the conversation shaping the future of medicine. #cellandgene #meetingonthemesa #EnvisionPharmaGroup #lifesciences

We're excited to share an insightful deep dive by Suki Kandola, Global Head of Value & Access, on the latest updates in the AMCP Format for Formulary Submissions Version 5.0., covering value-based care, early engagement strategies, and the importance of real-world evidence and health disparities. This piece highlights practical strategies for navigating these changes, ensuring successful product launches and better patient access. Advancing with these new insights is crucial for staying ahead in the healthcare landscape, accelerating formulary submissions, and improving patient outcomes. https://lnkd.in/gRgn_35a   #Healthcare #Pharma #ValueBasedCare #PatientAccess #RealWorldEvidence #EnvisionPharma

Many AI tools promise transformative results. Few are designed with the rigor and human touch required for medical decision-making.   4Sight is different.   Backed by over 20 years of industry experience, our platform leverages state-of-the-art AI and deep human expertise to deliver actionable insights that resonate with healthcare professionals and drive measurable healthcare outcomes.   Discover how 4Sight can transform your organization. 👇 https://lnkd.in/ebpfniPR #MedAffairs #AIinHealthcare #LifeSciences